Владимир Викторович Илюха
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Владимир Викторович Илюха has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Элина Валерьевна Панова
Петрозаводский государственный университет
3 shared publications - Aleksandra Kizhina
Institute of Biology, Karelian Research Centre of the Russian Academy of Sciences
2 shared publications - Alexander Poltorak
Department of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA
2 shared publications - M. S. Maschinskas
Petrozavodsk State University
2 shared publications Alexei Degterev
Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, USA
1 shared publicationAnton Buzdin
D. Rogachyov Federal Research Center of Pediatric Hematology, Oncology and Immunology, Moscow 117997, Russia
1 shared publication
Latest Publications
- Open Access
- 16 April 2024
- Published by Cifra Ltd - Russian Agency for Digital Standardization (RADS) in ZHurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia»
- Vol. 68 (1) , 109-113
Биологическое действие экстракта листьев стевии на обменные процессы мышей С57BL/6
Цель исследования – изучение влияния хронического употребления экстракта листьев стевии (ЭЛС, Stevia rebaudiana Bertoni), широко применяемой как сахарозаменитель, на биохимические показатели крови и состояние внутренних органов половозрелых самок мышей (Mus musculus domesticus) линии C57BL/6. Методика. Животные были разделены на 3 группы: контрольную и 2 опытных, получавших водный раствор экстракта листьев стевии по 1 (допустимая суточная доза – ДСД) и 10 мг/г массы тела соответственно в течение 2-х мес. Результаты. Показано повышение общего холестерина, снижение триацилглицеридов (ТАГ) и глюкозы крови, без дозозависимого эффекта. Установлено снижение массы поджелудочной железы и печени, а также сердца исключительно в группе получавшей ДСД экстракта. В этой же группе наблюдалось увеличение массы почек и селезенки. Кроме того прием экстракта приводил к изменению цвета почек, селезенки и печени, а в некоторых случаях к гидронефротическим изменениям почек. Заключение. Таким образом, хроническое употребление ЭЛС оказывает как положительный, так и отрицательный эффект, что обуславливает необходимость более точного определения ДСД экстракта. Aim: To study the effect of chronic treatment with stevia (Stevia rebaudiana Bertoni) leaf extract (SLE), that is widely used as a sweetener, on blood biochemistry and the state of internal organs in sexually mature C57BL/6 female mice (Mus musculus domesticus). Methods. Animals were divided into three groups: a control group and two experimental groups. The mice received a SLE water solution at doses of one (permissible daily dose, PDD) and 10 mg/g of body weight, respectively, for two months. Results. The study showed an increase in total cholesterol and decreases in triacylglycerols and blood glucose without a dose-dependent effect. Decreases in the weight of the pancreas, liver, and heart were observed only in the group receiving the SLE at PDD. In the same group, increases in the weight of the kidneys and spleen were observed. Also, the SLE treatment resulted in discoloration of the kidneys, spleen and liver, and, in some cases, hydronephrotic changes in the kidneys. Conclusion. Thus, the chronic treatment with the SLE had both positive and negative effects, which necessitates a more accurate determination of the SLE PDD.
- 16 April 2024
- Published by Cifra Ltd - Russian Agency for Digital Standardization (RADS) in ZHurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia»
- Vol. 68 (1) , 109-113
Open AccessБиологическое действие экстракта листьев стевии на обменные процессы мышей С57BL/6
Цель исследования – изучение влияния хронического употребления экстракта листьев стевии (ЭЛС, Stevia rebaudiana Bertoni), широко применяемой как сахарозаменитель, на биохимические показатели крови и состояние внутренних органов половозрелых самок мышей (Mus musculus domesticus) линии C57BL/6. Методика. Животные были разделены на 3 группы: контрольную и 2 опытных, получавших водный раствор экстракта листьев стевии по 1 (допустимая суточная доза – ДСД) и 10 мг/г массы тела соответственно в течение 2-х мес. Результаты. Показано повышение общего холестерина, снижение триацилглицеридов (ТАГ) и глюкозы крови, без дозозависимого эффекта. Установлено снижение массы поджелудочной железы и печени, а также сердца исключительно в группе получавшей ДСД экстракта. В этой же группе наблюдалось увеличение массы почек и селезенки. Кроме того прием экстракта приводил к изменению цвета почек, селезенки и печени, а в некоторых случаях к гидронефротическим изменениям почек. Заключение. Таким образом, хроническое употребление ЭЛС оказывает как положительный, так и отрицательный эффект, что обуславливает необходимость более точного определения ДСД экстракта. Aim: To study the effect of chronic treatment with stevia (Stevia rebaudiana Bertoni) leaf extract (SLE), that is widely used as a sweetener, on blood biochemistry and the state of internal organs in sexually mature C57BL/6 female mice (Mus musculus domesticus). Methods. Animals were divided into three groups: a control group and two experimental groups. The mice received a SLE water solution at doses of one (permissible daily dose, PDD) and 10 mg/g of body weight, respectively, for two months. Results. The study showed an increase in total cholesterol and decreases in triacylglycerols and blood glucose without a dose-dependent effect. Decreases in the weight of the pancreas, liver, and heart were observed only in the group receiving the SLE at PDD. In the same group, increases in the weight of the kidneys and spleen were observed. Also, the SLE treatment resulted in discoloration of the kidneys, spleen and liver, and, in some cases, hydronephrotic changes in the kidneys. Conclusion. Thus, the chronic treatment with the SLE had both positive and negative effects, which necessitates a more accurate determination of the SLE PDD.
- Open Access
- 8 March 2024
- Published by Moscow University Press in Vestnik Moskovskogo universiteta. Seria 16. Biologia
- Vol. 78 (№4, 2023) , 273-277
EFFECT OF DIFFERENT SWEETENERS ON GLYCOGEN CONTENT OF BLOOD LEUKOCYTES AND DIFFERENTIAL LEUKOCYTE COUNTS IN C57BL/6 MICE
We studied the eff ect of stevia leaf extract, saccharinate and cyclamate in various dosages on the glycogen content of blood leukocytes in mice, as a necessary substrate for the realization of phagocytosis. An increase of glycogen content was found in all experimental groups which obtained sweeteners at a dosage of 10 mg/g of body weight. The eff ect of sweeteners on the diff erential leukocyte counts was found only for mice treated with stevia leaf extract at a dosage of 10 mg/g of body weight. They demonstrated increase of neutrophil-to-lymphocyte ratio. New data expand our understanding of the metabolism of sugar substitutes in the organism and their eff ect on physiological systems, in particular the hematopoietic and immune systems.
- 8 March 2024
- Published by Moscow University Press in Vestnik Moskovskogo universiteta. Seria 16. Biologia
- Vol. 78 (№4, 2023) , 273-277
Open AccessEFFECT OF DIFFERENT SWEETENERS ON GLYCOGEN CONTENT OF BLOOD LEUKOCYTES AND DIFFERENTIAL LEUKOCYTE COUNTS IN C57BL/6 MICE
We studied the eff ect of stevia leaf extract, saccharinate and cyclamate in various dosages on the glycogen content of blood leukocytes in mice, as a necessary substrate for the realization of phagocytosis. An increase of glycogen content was found in all experimental groups which obtained sweeteners at a dosage of 10 mg/g of body weight. The eff ect of sweeteners on the diff erential leukocyte counts was found only for mice treated with stevia leaf extract at a dosage of 10 mg/g of body weight. They demonstrated increase of neutrophil-to-lymphocyte ratio. New data expand our understanding of the metabolism of sugar substitutes in the organism and their eff ect on physiological systems, in particular the hematopoietic and immune systems.
- 1 December 2023
- Published by Allerton Press in Moscow University Biological Sciences Bulletin
- Vol. 78 (4) , 263-267
Effect of Various Sweeteners on Glycogen Content of Blood Leukocytes and Differential Leukocyte Count in C57BL/6 Mice
The effect of stevia leaf extract, saccharinate, and cyclamate in various dosages on the glycogen content of blood leukocytes in C57BL/6 mice as a necessar
- 1 December 2023
- Published by Allerton Press in Moscow University Biological Sciences Bulletin
- Vol. 78 (4) , 263-267
Effect of Various Sweeteners on Glycogen Content of Blood Leukocytes and Differential Leukocyte Count in C57BL/6 Mice
The effect of stevia leaf extract, saccharinate, and cyclamate in various dosages on the glycogen content of blood leukocytes in C57BL/6 mice as a necessar
- Open Access
- 4 January 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-13
ZBP1 promotes LPS-induced cell death and IL-1β release via RHIM-mediated interactions with RIPK1
Inflammation and cell death are closely linked arms of the host immune response to infection, which when carefully balanced ensure host survival. One example of this balance is the tightly regulated transition from TNFR1-associated pro-inflammatory complex I to pro-death complex II. By contrast, here we show that a TRIF-dependent complex containing FADD, RIPK1 and caspase-8 (that we have termed the TRIFosome) mediates cell death in response to Yersinia pseudotuberculosis and LPS. Furthermore, we show that constitutive binding between ZBP1 and RIPK1 is essential for the initiation of TRIFosome interactions, caspase-8-mediated cell death and inflammasome activation, thus positioning ZBP1 as an effector of cell death in the context of bacterial blockade of pro-inflammatory signaling. Additionally, our findings offer an alternative to the TNFR1-dependent model of complex II assembly, by demonstrating pro-death complex formation reliant on TRIF signaling.
- 4 January 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-13
Open AccessZBP1 promotes LPS-induced cell death and IL-1β release via RHIM-mediated interactions with RIPK1
Inflammation and cell death are closely linked arms of the host immune response to infection, which when carefully balanced ensure host survival. One example of this balance is the tightly regulated transition from TNFR1-associated pro-inflammatory complex I to pro-death complex II. By contrast, here we show that a TRIF-dependent complex containing FADD, RIPK1 and caspase-8 (that we have termed the TRIFosome) mediates cell death in response to Yersinia pseudotuberculosis and LPS. Furthermore, we show that constitutive binding between ZBP1 and RIPK1 is essential for the initiation of TRIFosome interactions, caspase-8-mediated cell death and inflammasome activation, thus positioning ZBP1 as an effector of cell death in the context of bacterial blockade of pro-inflammatory signaling. Additionally, our findings offer an alternative to the TNFR1-dependent model of complex II assembly, by demonstrating pro-death complex formation reliant on TRIF signaling.
- 15 July 2017
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 199 (2) , 397-402
Cutting Edge: Activation of STING in T Cells Induces Type I IFN Responses and Cell Death
Stimulator of interferon genes (STING) was initially described as a sensor of intracellular bacterial and viral DNA and a promising adjuvant target in innate immune cells; more recently STING has also been shown to detect endogenous DNA and play a role in tumor immunity and autoimmune disease development. Thus far STING has been studied in macrophages and dendritic cells. In this study, to our knowledge we provide the first evidence of STING activation in T cells, in which STING agonists not only provoke type I IFN production and IFN-stimulated gene expression, mirroring the response of innate cells, but are also capable of activating cell stress and death pathways. Our results suggest a re-evaluation of STING agonist–based therapies may be necessary to identify the possible effects on the T cell compartment. Conversely, the effects of STING on T cells could potentially be harnessed for therapeutic applications.
- 15 July 2017
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 199 (2) , 397-402
Cutting Edge: Activation of STING in T Cells Induces Type I IFN Responses and Cell Death
Stimulator of interferon genes (STING) was initially described as a sensor of intracellular bacterial and viral DNA and a promising adjuvant target in innate immune cells; more recently STING has also been shown to detect endogenous DNA and play a role in tumor immunity and autoimmune disease development. Thus far STING has been studied in macrophages and dendritic cells. In this study, to our knowledge we provide the first evidence of STING activation in T cells, in which STING agonists not only provoke type I IFN production and IFN-stimulated gene expression, mirroring the response of innate cells, but are also capable of activating cell stress and death pathways. Our results suggest a re-evaluation of STING agonist–based therapies may be necessary to identify the possible effects on the T cell compartment. Conversely, the effects of STING on T cells could potentially be harnessed for therapeutic applications.